Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists".
Resource Type
Editorial & Opinion
Authors
Hong LT; Loma Linda University School of Pharmacy, Loma Linda, California, USA.; Downes KJ; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; FakhriRavari A; Loma Linda University School of Pharmacy, Loma Linda, California, USA.; Abdul-Mutakabbir JC; Loma Linda University School of Pharmacy, Loma Linda, California, USA.; Divisions of Clinical Pharmacy and Black Diaspora and African American Studies, University of California San Diego, La Jolla, California, USA.; Kuti JL; Center for Anti-Infective Research and Development, Hartford Hospital, Gainesville, Florida, USA.; Jorgensen S; University of Toronto, Toronto, Ontario, Canada.; Young DC; University of Utah College of Pharmacy, Salt Lake City, Utah, USA.; Alshaer MH; University of Florida College of Pharmacy, Gainesville, Florida, USA.; Bassetti M; University of Genoa, Genoa, Italy.; Bonomo RA; Cleveland Veteran Affairs Medical Center, Cleveland, Ohio, USA.; Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Case Western Reserve University, Cleveland, Ohio, USA.; Gilchrist M; Imperial College Healthcare National Health Services Trust, London, UK.; Jang SM; Loma Linda University School of Pharmacy, Loma Linda, California, USA.; Lodise T; Albany College of Pharmacy and Health Sciences, Albany, New York, USA.; Roberts JA; Faculty of Medicine, University of Queensland Center for Clinical Research, Brisbane, Queensland, Australia.; Herston Infectious Diseases Institute, Metro North Health, Brisbane, Queensland, Australia.; Departments of Pharmacy and Intensive Care, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.; Tängdén T; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Zuppa A; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Scheetz MH; College of Pharmacy, Pharmacometric Center of Excellence, Midwestern University, Downers Grove, Illinois, USA.; Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.
Source
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print Cited Medium: Internet ISSN: 1875-9114 (Electronic) Linking ISSN: 02770008 NLM ISO Abbreviation: Pharmacotherapy Subsets: MEDLINE